Retinopathy of prematurity has not been eliminated, as previously predicted, since the establishment of neonatal intensive care units in the late 1960s. '-3 Phelps estimates that 30% of infants with a birthweight of 1000 g or less will develop cicatricial disease with 8% becoming blind, and 2-2% of infants with a birthweight between 1001 and 1500 g will have cicatricial disease with 0-5% becoming blind. 4 As retinopathy of prematurity appears to be a multifactorial disease5 its prevention, even with the most accurate methods of monitoring blood gases, is probably impossible. (21) 46 (10) 3 (2) 211 (20) fibrovascular proliferation was mild to moderate. infants with a birthweight of between 751 g and These findings were accompanied by signs of plus 1000 g the incidence of acute retinopathy of predisease (presence of appreciable posterior pole maturity was 72%; it decreased to 35% in infants vascular tortuosity and dilatation and engorge-weighing between 1001 g and 1250 g and to 21% in ment of iris vessels). '7 Informed written consent was those weighing between 1251 g and 1500 g. The obtained from parents before the infants were incidence was still fairly high in infants weighing treated. between 1501 g and 2000 g (10%) but was only 2% Infants with a birthweight of -1800 g and all in those between 2001 g and 2500 g. Of the infants ventilated infants were seen at a neonatal follow up with acute retinopathy, 105 (50%) had retinopathy clinic for neurological and developmental evaluation stage 1; 58 (28%) had stage 2, and 48 (22%) stage 3 and ophthalmologic examination within one month (Table 2) . of discharge from the unit, or earlier if active Cryotherapy was usually performed on both eyes, retinopathy was present. Subsequently, the infants but if only one eye required treatment the better eye were seen at regular intervals. Infants with a birth-was not initially treated. Of the infants weighing weight of S1500 g were followed up to the age of 8 -1000 g, 26% of the survivors were treated ( (Table 1 ). In follow up 37 (18%) of these infants had cicatricial 13 15 As different classifications of the disease are used it is not always possible to compare results. The timing and method of treatment has also varied. In some centres cryotherapy has been performed only at a late stage of development of the disease, and the rate of success has been low or the condition has worsened. In most studies treatment has been performed on the demarcation line and neovascular ridge.
We treated our patients after the disease had advanced to acute stage 3 retinopathy, according to definite criteria. Cryotherapy was applied only to the avascular retina. Cryotherapy was performed in 4% of our surviving population and in 9% of infants with a birthweight of 1500 g or less (26% of infants with acute retinopathy). After treatment the eyes were examined routinely at least weekly.
Infants with a birthweight of 1800 g or less and the larger ventilated infants were followed in a special follow up clinic. Thirty seven (18%) of 211 infants with acute retinopathy have cicatricial disease stage 1 and 14 (7%) stage 2. None of the infants were blind or had serious visual impairment (cicatricial disease > stage 2). By the estimation of Phelps the expected incidence of blindness in our population was at least eight infants with more than twice that having severe cicatricial disease. Infants admitted to our unit in 1975 and 1976 were not included in this study as routine ophthalmological examinations were not performed as often as after 1976. Cryotherapy was used, however, when indicated, and no infant given cryotherapy has become blind or has serious visual impairment. As no other factor in the treatment of these infants explains the lack of any severe disease of the eyes in this large group of high risk infants our method of treatment seems to prevent severe cicatricial disease.
Hittner et al suggested a possible mechanism to support the treatment of the avascular retina only. 
